Clinical Trial

HeartStart FRx Defibrillator Event Registry

Recruiting
View on ClinicalTrials.gov →
Summary
This post market clinical follow-up study is a multi-center, non-randomized, unblinded, observational registry of the performance of the FRx Automated external defibrillator (AED) used in conjunction with electrodes with or without use of the infant/child key. The registry is focused only on on post-event data collection and does not prescribe any device usage. This registry has several safeguards in place to prevent against selections bias, including enrollment of all participants who have pads placed. This registry will evaluate the safety and verify the clinical performance of the device in relation to its claims, when used in accordance with the Device Manual.
Protocol Amendment History 3 changes
notable Sponsor changed: Philips Clinical & Medical Affairs Global -> Heartstream US LLC 2026-08-12
notable Primary completion pushed: 2027-12 -> 2030-12-31 2026-08-12
minor Completion pushed: 2027-12 -> 2030-12-31 2026-08-12
Trial Details
NCT Number NCT04250857
Lead Sponsor Heartstream US LLC
Conditions Sudden Cardiac Arrest
Enrollment 1,400 participants
Start Date 2019-11-04
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-11